Ophthalmology

 Vertex, CRISPR Therapeutics treated a patient using CRISPR In the very first, a patient diagnosed with Beta thalassemia was treated using CRISPR gene editing tool by Vertex and CRISPR Therapeutics.  CTX001 used to treat the disease, was extracted from hematopoietic stem cells from patients, engineered ex vivo using cas-9. The use of cas-9 to produce high levels of fetal hemoglobin in red blood cells will help to lessen down the need for blood transfusion. Cures for Dry Eyes ahead Dry eyes result in loss of goblet cells,glycocalyx mucin and corneal and conjunctival epithelial cell damage’ referred to as hyperosmolarity-triggered inflammatory cascade. ...